Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SPNT | RGA |
|---|---|---|
| Price | $24.50 | $251.04 |
| Change today | ▲ 0.33% | ▲ 0.65% |
| Market cap | $2.85B | $16.39B |
| Return, 3 months | +0.0% | +9.5% |
| Return, year to date | +11.9% | +25.2% |
| Return, 1 year | +34.5% | +29.7% |
| P/E (TTM) | 6.0 | 11.1 |
| P/B | 1.3 | 1.2 |
| P/E percentile vs own 5y | 41st | 9th |
| Dividend yield | – | 1.48% |
| Revenue growth (YoY, latest qtr) | – | +18.2% |
| Net profit growth (YoY) | – | +156.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 5.8% |
| Return on equity | – | 11.7% |
| Analyst target vs. price | +22.4% | +11.9% |
| Analyst buy share | 100% | 75% |
| RSI (14) | 49 | 57 |
| 30-day volatility | 18.3% | 17.4% |
| Max drawdown, 1 year | -14.7% | -12.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
